;   Medical Translation Insight: Consolidation in the pharmaceutical industry - ForeignExchange Translations

Consolidation in the pharmaceutical industry

Yesterday, the New York Times ran a piece about J&J's possible reactions to the pending Merck/Schering-Plough merger. The article contained an interesting look at mergers and acquisitions in the pharmaceutical industry over the past 15 or so years:

For medical translation service providers, this is both good and bad news: On the one hand, mergers provide work through rebranding, integration, and legal efforts. On the other hand, consolidation means that overall, the net words translated get reduced. So it's no wonder that there is a lot of hand-wringing in the translation business anytime a new pharma merger is announced.

Like this post? Subscribe to Medical Translation Insight via email or RSS!


  1. Jim medical translation said...
    This is only bad - bad for the industry and bad for us translators.
    Michael said...
    And even more important - bad news for the patients as it slows down true innovation.

Post a Comment


Services | Resources | Company | Contact Us | Blog | Home

(c) Copyright 2010, ForeignExchange Translations, Inc.